Research Progress and Application Prospects of Low-Affinity Nerve Growth Factor Receptor (LNIR) Antibodies
16 Apr 2026
by AntBio
Research Progress and Application Prospects of Low-Affinity Nerve Growth Factor Receptor (LNIR) Antibodies
Official Academic Review by ANT BIO PTE. LTD.
Literature Information
This review systematically summarizes the molecular structure, signaling networks, antibody engineering strategies, and translational applications of LNIR (p75NTR), a key neurotrophin receptor involved in neural development, cell survival, apoptosis, and disease progression. It evaluates preclinical advances of LNIR‑targeted antibodies in neurodegeneration, nerve injury, oncology, and regenerative medicine.
Research Background
LNIR is a 75 kDa transmembrane receptor of the TNF receptor superfamily that modulates neurotrophin signaling, cell fate decisions, and tissue homeostasis. Dysregulation of LNIR is closely linked to neurodegenerative diseases, cancer progression, and inflammatory disorders. High‑quality research tools are essential to dissect its complex biology and develop targeted therapies.
Research Approach
This analysis integrates structural biology, signaling pathway dissection, antibody engineering, and preclinical efficacy data to clarify LNIR function and evaluate therapeutic antibody potential. It emphasizes the need for validated reagents to support consistent, reproducible research.
Key Findings
- LNIR regulates neuronal survival, apoptosis, axon growth, and immune modulation through multiple signaling axes.
- LNIR antibodies show therapeutic promise in neurodegenerative diseases, nerve repair, and cancer therapy.
- Antibody engineering has enabled humanized, high‑affinity, and function‑selective LNIR‑targeting reagents.
- Reliable antibodies, proteins, and assay kits are critical for advancing mechanistic and translational studies.
Product Empowerment by ANT BIO PTE. LTD.
ANT BIO PTE. LTD. provides a complete suite of research tools to support LNIR‑related studies:
- Absin: General buffers, lysis reagents, ELISA kits, IHC kits, and detection systems.
- Starter: Highly specific monoclonal and polyclonal antibodies against LNIR, phosphorylated LNIR, and pathway components.
- UA: Recombinant LNIR protein, mutant variants, and functional standards for quantitative assays.
These reagents enable robust detection, quantification, and functional analysis of LNIR expression and activity.
Brand Mission
ANT BIO PTE. LTD. is a leading provider of premium life science reagents, including antibodies, recombinant proteins, assay kits, and general laboratory chemicals. Our three specialized sub‑brands—Absin, Starter, and UA—deliver tailored solutions to accelerate scientific discovery and therapeutic development.
Related Product List
表格
| Sub‑Brand | Product Category | Representative Products for LNIR Research |
|---|---|---|
| Absin | General reagents & kits | Lysis buffers, ELISA kits, IHC detection kits |
| Starter | Antibodies | Anti‑LNIR antibody, anti‑p‑LNIR antibody, neurotrophin pathway antibodies |
| UA | Recombinant proteins | LNIR recombinant protein, functional control proteins |
Official Brand Promotion
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights
